Original news and analysis on international IP policy
An academic conference this month will explore issues related to innovation, research and competition in the European Union, addressing topics such as 5G, big data, patents and standards.
The World Health Organization has concluded a major one-day forum on fair pricing of medicines, bringing a wide range of stakeholders together in Amsterdam and coming up with several possible actions for the way ahead. Key points of discussion included a definition of fair pricing, moving away from value-based pricing, delinkage of price from research and development costs, and greater transparency, according to participants.
Two new studies published by the World Health Organization provide insight on the production of pharmaceutical products in India and China. According to the studies, China has a substantial local pharmaceutical manufacturing sector which the Chinese government is closely linking to its policy objective of universal health care. India, the main global provider of generic medicines is not pursuing a comparable focus on universal health care. India is increasingly faced with Chinese pharmaceutical sector competition, with China being its main provider of commoditized active pharmaceutical ingredients (APIs).
A recent article in the journal Nature Biotechnology finds that since a key United States Supreme Court decision, the European Union and United States have diverged in their patent filings for medical diagnostics.
The Drugs for Neglected Diseases initiative (DNDi) has launched a collaborative project with five universities in India, United Kingdom, and the United States to help with the research on a debilitating neglected disease.
Antony Taubman, director of the World Trade Organization Intellectual Property Division, has been in a good position to view the world and intellectual property for some time. Today, designated as World IP Day, we caught up with him to ask his views on the theme this year.
The United States Department of Defense has announced that it intends to grant Sanofi Pasteur, a French pharmaceutical corporation, exclusive rights to develop a vaccine for the Zika virus. The decision follows outcry from the public and civil society groups over concerns of affordability and accessibility in taking such a step.
Inventions to contribute to the 2030 United Nations Sustainable Development Goals have been rewarded. A reactor which converts carbon dioxide into ethanol, a method for the detection of pesticides and contaminants in food, and renewable leather created from bacteria won the heart of the jury.
For World Intellectual Property Day this year, the World Intellectual Property Organization held a discussion on “Innovation in Communication: A State of Mind,” with a creator designer, a brand consultant and a writer as the panel.
The European Patent Office has a “tradition of looking forwards” to anticipate patenting trends, and it sees the Internet of Things (IoT) as the next challenge, Chief Economist Yann Ménière said at 20 April OxFirst webinar on the office's contribution to the coming world of billions of connected objects.
A group of 15 US and foreign tech and automobile companies and organisations has sent a letter to the White House asking for support to reduce what they see as rising anti-competitive licensing practices involving standards essential patents (SEPs).
Five years after health institutions and actors including pharmaceutical companies endorsed the London Declaration on Neglected Tropical Diseases, meant to support the World Health Organization to control and eradicate 10 specific diseases by 2020, new commitments were announced today (18 April) in Geneva.